Fight: A Phase 3 Randomized, Double-Blind, Placebo Controlled Study Evaluating (Bemarituzumab) Fpa144 And Modified Folfox6 (Mfolfox6) In Patients With Previously Untreated Advanced Gastric And Gastroesophageal Cancer With A Dose Finding Phase 1 Lead-In.
JOURNAL OF CLINICAL ONCOLOGY（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要